BMI: Weight Change Among Users of Three Progestin-Only Methods of Contraception Over a 12-Month Time Period
Study Details
Study Description
Brief Summary
The purpose of this study is to learn whether women who use progestin-only methods of birth control such as the contraceptive implant (Implanon), the levonorgestral-releasing IUS (Mirena), or depot medroxyprogesterone acetate(DMPA) will experience weight change compared to women using the non-hormonal copper IUC (ParaGard).
The investigators primary hypothesis is that users of DMPA will gain excess weight and increase their BMI above the copper-IUC users; secondarily, the investigators will compare users' data in the LNG-IUC and ENG implant groups to the copper-IUC group.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Outcome Measures
Primary Outcome Measures
- Weight [Baseline and 12 months]
Change in weight from baseline at 12 months.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients enrolled in CHOICE between the ages of 18 and 45 who consented to future studies
-
Chose levonorgestrel-releasing IUD, copper IUD, the implant, or DMPA as their CHOICE baseline method
-
Has baseline height and weight data collected from the on-campus enrollment site
-
Able to come back to the on-campus enrollment site for consent process and enrollment activities
Exclusion Criteria:
-
Recent history of DMPA use before starting their baseline CHOICE method
-
Used current method for less than 11 months or more than 12 months and three weeks
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Washington University School of Medicine | Saint Louis | Missouri | United States | 63110 |
Sponsors and Collaborators
- Washington University School of Medicine
Investigators
- Principal Investigator: Tessa E Madden, MD, MPH, Washington University School of Medicine
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- 201102211